
Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature
Zinzani, P.L., Sasse, S., Radford, J., Shonukan, O., Bonthapally, V.Volume:
95
Langue:
english
Journal:
Critical Reviews in Oncology/Hematology
DOI:
10.1016/j.critrevonc.2015.03.011
Date:
September, 2015
Fichier:
PDF, 63 KB
english, 2015